Ohio Public Employees Retirement System (OPERS)’s Pacira BioSciences PCRX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	41,385 +3,845	+10%	+$90.9K	﹤0.01%	1309
2026 Q1	$848K	Buy	37,540 +82	+0.2%	+$1.82K	﹤0.01%	1357
2025 Q4	$969K	Sell	37,458 -30,249	-45%	-$719K	﹤0.01%	1350
2025 Q3	$1.74M	Sell	67,707 -19,269	-22%	-$473K	0.01%	1163
2025 Q2	$2.08M	Buy	86,976 +56	+0.1%	+$1.41K	0.01%	1080
2025 Q1	$2.16M	Sell	86,920 -4,272	-5%	-$102K	0.01%	1041
2024 Q4	$1.72M	Buy	91,192 +90,769	+21,458%	+$1.59M	0.01%	1199
2024 Q3	$6.37K	Buy	423 +220	+108%	+$3.76K	﹤0.01%	2161
2024 Q2	$5.81K	Buy	203 +105	+107%	+$2.99K	﹤0.01%	1967
2024 Q1	$2.86K	Buy	+98	New	+$3.01K	﹤0.01%	1954
2019 Q4	–	Sell	-10,259	Closed	-$391K	–	1922
2019 Q3	$391K	Sell	10,259 -450	-4%	-$18K	﹤0.01%	1372
2019 Q2	$466K	Sell	10,709 -29,979	-74%	-$1.27M	﹤0.01%	1347
2019 Q1	$1.55M	Buy	40,688 +8,286	+26%	+$323K	0.01%	1075
2018 Q4	$1.39M	Sell	32,402 -5,181	-14%	-$242K	0.01%	1024
2018 Q3	$1.85M	Sell	37,583 -7,870	-17%	-$340K	0.01%	1049
2018 Q2	$1.46M	Sell	45,453 -5,794	-11%	-$200K	0.01%	1170
2018 Q1	$1.6M	Buy	51,247 +4,159	+9%	+$148K	0.01%	1106
2017 Q4	$2.15M	Buy	47,088 +6,914	+17%	+$274K	0.01%	1016
2017 Q3	$1.51M	Buy	40,174 +2,808	+8%	+$113K	0.01%	1131
2017 Q2	$1.78M	Buy	+37,366	New	+$1.73M	0.01%	1033

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s PCRX Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) increased its Pacira BioSciences (PCRX) stake by 10% in Q2 2026, buying an estimated $90.9K and bringing the position to 41,385 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Ohio Public Employees Retirement System (OPERS) first reported a position in PCRX in Q2 2017 and has held it in 20 quarters since. The position peaked at $2.16M in Q1 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Ohio Public Employees Retirement System (OPERS) held 41,385 shares of Pacira BioSciences worth $1.05M as of Q2 2026.
Ohio Public Employees Retirement System (OPERS) bought 3,845 Pacira BioSciences shares in Q2 2026, an estimated $90.9K.
Pacira BioSciences made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1309 holding.
Ohio Public Employees Retirement System (OPERS) first reported a position in Pacira BioSciences in Q2 2017 and has held it in 20 quarters since.
Ohio Public Employees Retirement System (OPERS)'s Pacira BioSciences position peaked at $2.16M in Q1 2025.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.